title: Conference scene: Select Biosciences Epigenetics Europe 2010.
abstract: The field of epigenetics is now on a geometric rise, driven in a large part by the realization that modifiers of chromatin are key regulators of biological processes in vivo. The three major classes of epigenetic effectors are DNA methylation, histone post-translational modifications (such as acetylation, methylation or phosphorylation) and small noncoding RNAs (most notably microRNAs). In this article, I report from Select Biosciences Epigenetics Europe 2010 industry conference held on 14-15 September 2010 at The Burlington Hotel, Dublin, Ireland. This industry conference was extremely well attended with a global pool of delegates representing the academic research community, biotechnology companies and pharmaceutical companies, as well as the technology/tool developers. This conference represented the current state of the epigenetics community with cancer/oncology as a key driver. In fact, it has been estimated that approximately 45% of epigenetic researchers today identify cancer/oncology as their main area of focus vis-à-vis their epigenetic research efforts.
authors: Systems Bioscience, 265 North Whisman Rd, Mountain View, CA 94043, USA. erazvi@earthlink.net
authors: Enal S
authors: ES
authors: Razvi
mesh_terms: D003226:Congresses as Topic; D057890:Epigenomics / Q000379:methods* / Q000639:trends; D005060:Europe; D012106:Research / Q000639:trends*